Practical resources and guidelines to support oncologists in their daily work.
CLINICAL PRACTICE GUIDELINES
GUIDELINES AND FRAMEWORKS
BIOMARKERS
Optimising the use of biomarkers: actionability and tumour agnostic potential
ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
A systematic framework to rank molecular alterations by evidence for benefit when targeted by precision therapeutics.
ESMO Tumour-Agnostic Classifier and Screener (ETAC-S)
A screening tool for tumour-agnostic potential of molecularly guided treatments.
ESMO Scale of Minimum Requirements for AI Biomarkers in Oncology (EBAI) *in progress*
A framework to ensure clinically validated artificial intelligence biomarkers safely and effectively support clinical decision making.
BIG DATA & AI
Defining standards for the generation and integration of big data and artificial intelligence in oncology care
ESMO Adaptation of Lines of Systemic Therapy (ENLIST)
Definitions and rules to increase uniformity for assigning lines of systemic therapy in solid tumours.
ESMO Guidance on the Use of Large Language Models in Clinical Practice (ELCAP)
Practical, case-based recommendations for the safe and effective use of LLMs in clinical oncology.
ESMO Guidance for Reporting Oncology Real-World Evidence (ESMO-GROW) *in progress*
Standardised reporting recommendations to streamline the presentation and interpretation of oncology RWE.
POINT OF CARE
Evidence-based guidance supporting clinical decision making for state of the art patient management
ESMO CLINICAL PRACTICE GUIDELINES
Expert, evidence-based recommendations to standardise and optimise cancer care – now available in multiple formats and as living guidelines.
ESMO CHECKLISTS
Practical tools to verify that essential ESMO Guideline-recommended steps in cancer patient care are followed in daily practice.
ESMO-ESTRO STATEMENTS
Consensus recommendations on safely combining radiotherapy with targeted therapies.
Pan-Asian Guidelines Adaptation (PAGA)
Customised ESMO Clinical Practice Guidelines for the Asian clinical context for harmonised, evidence-based cancer care.